BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3822789)

  • 21. Effect of metronidazole on the radiocurability and oxygenation of the C3HBA tumor.
    Haynes MJ; Inch WR
    Radiat Res; 1976 Oct; 68(1):184-9. PubMed ID: 967973
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD; Maimonis P; Michaels HB; Sedlacek R
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
    Ono K; Takahashi M; Hamanaka D; Hiraoka M; Nishidai T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):370-6. PubMed ID: 6223274
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
    Rockwell S; Irvin CG; Nierenburg M
    Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
    Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
    Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
    Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
    Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing of hypoxic cell radiosensitizers in vivo.
    Rauth AM; Chin J; Marchow L; Paciga J
    Br J Cancer Suppl; 1978 Jun; 3():202-5. PubMed ID: 277228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiosensitization effect of new hypoxic cell radiosensitizer RK-27 on normal tissue and Ehrlich tumor of experimental animals].
    Kohda Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Apr; 48(4):497-508. PubMed ID: 3231514
    [No Abstract]   [Full Text] [Related]  

  • 31. 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
    Wiedenmann N; Valdecanas D; Hunter N; Hyde S; Buchholz TA; Milas L; Mason KA
    Clin Cancer Res; 2007 Mar; 13(6):1868-74. PubMed ID: 17363543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 33. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
    Shibamoto Y; Ono K; Takahashi M; Kano E; Hori H; Shibata T; Inayama S; Abe M
    Jpn J Cancer Res; 1986 Oct; 77(10):1027-33. PubMed ID: 3096918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
    Brown JM
    Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses.
    Oya N; Shibamoto Y; Sasai K; Sugiyama T; Abe M
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1113-9. PubMed ID: 8262836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
    Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative efficacy of high-pressure oxygen and misonidazole to reduce TCD50 of a mouse mammary carcinoma.
    Suit HD; Brown JM
    Br J Radiol; 1979 Feb; 52(614):159-60. PubMed ID: 427373
    [No Abstract]   [Full Text] [Related]  

  • 38. Metronidazole and fractionated radiotherapy of a murine tumor.
    Stone HB
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1133-7. PubMed ID: 993090
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiosensitizers of hypoxic cells in solid tumors.
    Fowler JF; Adams GE; Denekamp J
    Cancer Treat Rev; 1976 Dec; 3(4):227-56. PubMed ID: 1016978
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
    Milas L; Hunter NR; Mason KA; Kurdoglu B; Peters LJ
    Cancer Res; 1994 Jul; 54(13):3506-10. PubMed ID: 7912167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.